CompanyDrug

Daiichi Sankyo’s Enhertu Accepted for Review in China for HER2-Low Breast Cancer

Policy / Regulatory

NHSA Proposes Regulations to Standardize Oral Implant Charges and Reduce Costs

CompanyDigital

Ping An Good Doctor Reports 2022 Interim Results with Revenue Decline and User Growth

Company

WuXi STA Breaks Ground on New US Manufacturing Site in Delaware

CompanyDeals

ZhenGe Biotech Secures RMB 100 Million in Series C+ Funding for CDMO Expansion

CompanyDrug

Zhejiang Erying’s Acetaminophen Set for CDE Priority Review in Pediatric Fever and Pain

Company

Henlius Pharma’s 2022 Interim Revenue Jumps 103.5% on Biosimilar Sales and Licensing

CompanyDeals

LongBio Pharma Raises Series A+ Funding to Advance Autoimmune Disease Drug Development

CompanyDrug

Fosun Kite’s Yescarta CAR-T Therapy Secures New Clinical Trial Approval in China

CompanyDeals

mProbe Raises Funds in Series B1 Round Led by AstraZeneca and CICC

CompanyDeals

Huahai Pharma to Manufacture Pfizer’s Paxlovid for China Market

CompanyDrug

Recbio Completes Phase II Trial Enrollment for ReCOV COVID-19 Vaccine